Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| TG(16:0/16:1(9Z)/20:1(11Z))[iso6] | CHEBI_89767 | |
| alpha-N-acetylneuraminyl-(2->3)-D-galactosyl group | CHEBI_75127 | [A galactosyl group derived from the disaccharide alpha-N-acetylneuraminyl-(2->3)-D-galactose. Implied reactive epitope within gangliosides LM1, GD1a and GT1b.] |
| galactosyl group | CHEBI_24164 | [A glycosyl group obtained by removing the hydroxy group from the hemiacetal function of a galactose and, by extension, of a lower oligosaccharide having galactose at the reducing end.] |
| alpha-Neu5Ac-(2->3)-D-Gal | CHEBI_61596 | [An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position] |
| CHEBI_75128 | CHEBI_75128 | |
| alpha-N-acetylneuraminyl-(2->6)-D-galactosyl group | CHEBI_75129 | [A galactosyl group derived from the disaccharide alpha-N-acetylneuraminyl-(2->6)-D-galactose.] |
| alpha-Neup5Ac-(2->6)-D-Galp | CHEBI_62511 | [An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 6-position] |
| N-(2-hydroxyphenyl)-N'-[(5-nitro-2-thiophenyl)methylideneamino]octanediamide | CHEBI_125180 | |
| (3aR,10bR)-5-[2-(benzenesulfonyl)ethyl]-2-[4-(3-hydroxypropoxy)phenyl]-3a-(phenylmethyl)-6,10b-dihydrooxazolo[4,5-d][2]benzazepin-4-one | CHEBI_125181 | |
| (3S,3'S,4'R,5'S)-5'-(2-hydroxyethyl)-5-iodo-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-1-prop-2-enyl-2-spiro[indole-3,2'-oxolane]one | CHEBI_125182 | |
| 2-[[1-[[3-(2-hydroxyethoxy)phenyl]methyl]-4-piperidinyl]methyl]isoindole-1,3-dione | CHEBI_125183 | |
| alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl group | CHEBI_75130 | [A sialosyl group derived from the disaccharide alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminic acid.] |
| sialosyl group | CHEBI_26668 | [A glycosyl group derived by removal of the exomeric hydroxy group from any of the sialic acids.] |
| alpha-Neup5Ac-(2->8)-alpha-Neup5Ac | CHEBI_62097 | [alpha-Neu5Ac-(2->8)-Neu5Ac in which the configuration at the anomeric carbon atom of the residue at the reducing end is alpha] |
| (3R,3'R,4'S,5'R)-5'-(2-hydroxyethyl)-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-1-[[4-(2-oxo-1-azetidinyl)phenyl]methyl]-2-spiro[indole-3,2'-oxolane]one | CHEBI_125184 | |
| 1-azocanyl-[(2R,4R)-2-(4-hydroxybutoxy)-4-thiophen-2-yl-3,4-dihydro-2H-pyran-6-yl]methanone | CHEBI_125185 | |
| DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol | CHEBI_75132 | [A racemate comprising equimolar amounts of (1R,2R)- and (1S,2S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol.] |
| N-(2-hydroxyphenyl)-N'-[(1-methyl-3-indolyl)methylideneamino]octanediamide | CHEBI_125186 | |
| N-acetylneuraminyl group | CHEBI_75133 | [A sialosyl group derived from N-acetylneuraminic acid.] |
| N-acetylneuraminic acid | CHEBI_17012 | [An N-acylneuraminic acid where the N-acyl group is specified as acetyl.] |